Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach

Detalles Bibliográficos
Autores principales: Kuscu, Ozlem Ozkan, Ergenoglu, Pinar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949026/
https://www.ncbi.nlm.nih.gov/pubmed/36844115
http://dx.doi.org/10.2478/rjaic-2021-0015
_version_ 1784892895948439552
author Kuscu, Ozlem Ozkan
Ergenoglu, Pinar
author_facet Kuscu, Ozlem Ozkan
Ergenoglu, Pinar
author_sort Kuscu, Ozlem Ozkan
collection PubMed
description
format Online
Article
Text
id pubmed-9949026
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-99490262023-02-24 Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach Kuscu, Ozlem Ozkan Ergenoglu, Pinar Rom J Anaesth Intensive Care Letter to Editor Sciendo 2022-12-29 /pmc/articles/PMC9949026/ /pubmed/36844115 http://dx.doi.org/10.2478/rjaic-2021-0015 Text en © 2021 Ozlem Ozkan Kuscu and Pinar Ergenoglu, published by Sciendo https://creativecommons.org/licenses/by-nc-nd/3.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
spellingShingle Letter to Editor
Kuscu, Ozlem Ozkan
Ergenoglu, Pinar
Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach
title Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach
title_full Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach
title_fullStr Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach
title_full_unstemmed Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach
title_short Use of Tociluzumab in the Thrombocytopenic COVID-19 Patient: A Challenge in the Therapeutic Approach
title_sort use of tociluzumab in the thrombocytopenic covid-19 patient: a challenge in the therapeutic approach
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949026/
https://www.ncbi.nlm.nih.gov/pubmed/36844115
http://dx.doi.org/10.2478/rjaic-2021-0015
work_keys_str_mv AT kuscuozlemozkan useoftociluzumabinthethrombocytopeniccovid19patientachallengeinthetherapeuticapproach
AT ergenoglupinar useoftociluzumabinthethrombocytopeniccovid19patientachallengeinthetherapeuticapproach

Ejemplares similares